Poland· PL-100424642
Novistig
A neostigmin, kombinationen product containing glycopyrronii bromidum + neostigmini methylsulfas, registered in Poland by Sintetica GmbH. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Neostigmin, kombinationen is registered in 6 of 19 countries.
Countries holding a registration under ATC N07AA51 (neostigmin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Neostigmin, kombinationen · ATC N07AA51
6 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Glycopyrronii bromidum + Neostigmini methylsulfas
- Manufacturer
- Sintetica GmbH
- Country
- Poland (PL)
- ATC code
- N07AA51
- ATC class
- Neostigmin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991454906
- gtin04150169111003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07AA51
Neostigmin, kombinationen, as other registers publish it.
- DenmarkCopnegEQL Pharma AB
- NorwayCopnegEQL Pharma AB
- FinlandCopnegEQL Pharma AB
- IrelandGlycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for InjectionMercuryPharm Ltd
- FinlandGlycostigminEvolan Pharma AB
- FinlandRobinul-NeostigminViatris Oy
- NorwayRobinul-NeostigminViatris AS
- DenmarkRobinul-NeostigminViatris ApS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5473763-56f5-46c6-9057-b827e7ab751d GET /v1/drugs/e5473763-56f5-46c6-9057-b827e7ab751d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "(0,5 mg + 2,5 mg)/ml",
"packaging": "05909991454906 ¦ Lz ¦ 140394\n10 amp. 1 ml\n¦ UR/Z/4c/061/22 - 04150169111003",
"substance": "Glycopyrronii bromidum 0,5 mg/ml + Neostigmini methylsulfas 2,5 mg/ml",
"common_name": "Glycopyrronii bromidum + Neostigmini methylsulfas",
"pl_product_id": "100424642",
"pozwolenie_nr": "26470",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about neostigmin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.